Pulmonary Fibrosis_Interstitial Lung Disease

Gene: KCNK3

Green List (high evidence)

KCNK3 (potassium two pore domain channel subfamily K member 3)
EnsemblGeneIds (GRCh38): ENSG00000171303
EnsemblGeneIds (GRCh37): ENSG00000171303
OMIM: 603220, ClinGen, DECIPHER
KCNK3 is in 9 panels

4 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

DEFINITIVE by ClinGen.
Created: 8 Aug 2023, 3:20 p.m. | Last Modified: 8 Aug 2023, 3:20 p.m.
Panel Version: 1.19

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Pulmonary hypertension, primary, 4 MIM#615344

Krithika Murali (Victorian Clinical Genetics Services)

Green List (high evidence)

LoF variants associated with PPAH
GoF variants associated with neurodevelopmental disorder
Created: 6 Oct 2022, 12:14 p.m. | Last Modified: 6 Oct 2022, 12:14 p.m.
Panel Version: 1.13

Suzanna Lindsey-Temple (Liverpool Hospital)

I don't know

The KCNK3 gene (alias Task-1) encodes a voltage-sensitive potassium channel which is expressed in pulmonary artery smooth muscle cells.

PMID: 23883380 - KCNK3 missense variants with incomplete penetrance have been identified in several families with adult-onset PAH.

PMID: 27649371- Single report of homozygous missense variant in KCNK3(c.316G>C; p.Gly106Arg) in a paediatric case of PAH. The child was diagnosed at the age of 2 months with a severe form of PAH and he underwent lung transplantation at the age of 5 years. His mother who was a heterozygous carrier was diagnosed at the age of 19, one year after giving birth, of severe PAH, requiring bilateral lung transplantation 26 months after diagnosis. The child’s father was an asymptomatic carrier of the same mutation in KCNK3. The authors hypothesize that in PAH due to mutations in KCNK3 incomplete dominance with worsening of the clinical features for homozygous carriers might be observed.
Created: 7 Nov 2021, 10:03 a.m. | Last Modified: 7 Nov 2021, 10:03 a.m.
Panel Version: 0.183

Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

Phenotypes
Pulmonary arterial hypertension.

Publications

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

Pulmonary arterial hypertension is the main feature of the condition caused by this gene.
Sources: Expert list
Created: 23 Jan 2020, 11:27 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Pulmonary hypertension, primary, 4 MIM#615344

Details

Mode of Inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Expert list
  • Expert list
Phenotypes
  • Pulmonary hypertension, primary, 4 MIM#615344
OMIM
603220
ClinGen
KCNK3
DECIPHER
KCNK3
Clinvar variants
Variants in KCNK3
Penetrance
None
Publications
Panels with this gene

History Filter Activity

16 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: kcnk3 has been classified as Green List (High Evidence).

16 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: kcnk3 has been classified as Green List (High Evidence).

16 Dec 2025, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: kcnk3 has been classified as Amber List (Moderate Evidence).

16 Dec 2025, Gel status: 2

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Chirag Patel (Genetic Health Queensland)

gene: KCNK3 was added gene: KCNK3 was added to Pulmonary Fibrosis_Interstitial Lung Disease. Sources: Expert Review Amber,Expert list Mode of inheritance for gene: KCNK3 was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal Publications for gene: KCNK3 were set to 23883380; 27649371 Phenotypes for gene: KCNK3 were set to Pulmonary hypertension, primary, 4 MIM#615344